Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nyse  >  AT&T    T

AT&T

(T)
  Report  
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsOfficial PublicationsSector newsMarketScreener StrategiesAnalyst Recommendations

Improving Healthcare One Step at a Time: AT&T and Nihon Kohden Boost Patient Outcomes Through Connectivity

share with twitter share with LinkedIn share with facebook
share via e-mail
0
02/11/2019 | 02:05pm EDT

Some 2,400 years ago, Hippocrates deemed walking the best medicine. And while it's no panacea, even modern physicians agree on its tremendous benefits to preventative care and recovery.

More and more clinicians are recognizing ambulation - a patient's ability to move after a medical operation - as a critical step in improving patient outcomes, both in and out of the hospital. And post-procedure mobility has proven time and again to shave days off of patient hospital stays. Plus, it results in significantly lower medical costs for patients and hospitals alike.

But while a few light walks throughout the hospital hallways seem like the miracle solution to fast-tracking patient recovery, it comes with significant challenges for hospitals. Inpatients need their vital signs monitored around the clock. And network-connected wearable monitoring devices - called telemeters - currently rely on a Wi-Fi connection to send data. So if a patient walks into a Wi-Fi dead zone in another hospital wing or wanders outdoors for fresh air, healthcare providers might miss critical alarms or abnormalities in the patient's vitals. That network limitation means nurses must accompany patients on these outings, resulting in increased costs and staffing resources for the hospital.

In an effort to untether patient ambulation from this catch-22, medical equipment manufacturer Nihon Kohden teamed up with the AT&T Foundry to solve this connectivity dilemma. The result was a prototype for a cellular 'travel pack' to ensure the uninterrupted capture of patient vitals data.

The travel pack device attaches to Nihon Kohden's wearable Life Scope® G3 telemeter. It automatically toggles between a hospital's Wi-Fi network and an LTE connection, depending on which signal is stronger in any given location. This ensures hospital staff continues receiving vital signs as the patient moves about the hospital and even outdoors.

But those near-real time data insights are useless if unassisted patients experience a medical emergency and staff can't find them. So, our Foundry team in Houston built in a GPS solution for more precise location tracking both inside and outside the hospital. If the device sends an alarm, hospital staff can more quickly and accurately provide in-person assistance.

We also developed a web interface for managing the G3 devices remotely. Nihon Kohden currently provides its own wireless patient monitoring solution to hospitals so they can better manage patient vital data and visualize patient status. The Foundry team integrated this solution into the device and developed a visual dashboard. This allows hospitals to view a variety of patient and network data statistics. For example, hospital staff can view alerts on patient vitals like respiration and blood-oxygen content alongside overall device data usage and most frequently used network connection.

Finally, the Foundry iterated on its initial prototype to make it more mobile and user-friendly. Once we had a complete working system, we miniaturized the travel pack into a more compact size, allowing it to better fit onto the patient's G3 device.

We're currently working with Nihon Kohden to trial this capability within a real hospital setting. But we see great potential beyond the clinical setting. In the future, AT&T's vision is to help Nihon Kohden provide seamless patient monitoring so physicians can deliver continuous, uninterrupted care wherever their patients may be.

Disclaimer

AT&T Inc. published this content on 11 February 2019 and is solely responsible for the information contained herein. Distributed by Public, unedited and unaltered, on 11 February 2019 19:04:06 UTC

share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on AT&T
05:24pAT&T : Pay-TV Subscribers Continue to Flee -- 4th Update
DJ
05:17pSuperheroes and a king may set movie records for Disney this summer
RE
04:57pAT&T : Pay-TV Subscribers Continue to Flee -- 3rd Update
DJ
04:33pANADARKO PETROLEUM : and eBay jump while iRobot and AT&T slump
AQ
01:43pAT&T : misses revenue estimates as it bleeds pay-TV subscribers
AQ
01:35pAT&T : misses revenue estimates as it bleeds pay-TV subscribers
AQ
12:45pAT&T : Pay-TV Subscribers Continue to Flee -- 2nd Update
DJ
12:00pMARKETS RIGHT NOW : Stocks edge lower a day after record
AQ
11:41aAT&T : misses revenue estimates as pay-TV subscribers bleed away
RE
10:41aSAMSUNG ELECTRONICS : AT&T reveals the gargantuan Samsung Galaxy View 2 tablet
AQ
More news
Financials ($)
Sales 2019 184 B
EBIT 2019 38 844 M
Net income 2019 19 896 M
Debt 2019 158 B
Yield 2019 6,38%
P/E ratio 2019 12,51
P/E ratio 2020 11,70
EV / Sales 2019 2,13x
EV / Sales 2020 2,07x
Capitalization 234 B
Chart AT&T
Duration : Period :
AT&T Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends AT&T
Short TermMid-TermLong Term
TrendsNeutralNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 29
Average target price 33,9 $
Spread / Average Target 5,7%
EPS Revisions
Managers
NameTitle
Randall L. Stephenson Chairman, President & Chief Executive Officer
John J. Stephens CFO, Principal Accounting Officer & Senior EVP
Joyce M. Roché Independent Director
Laura D'Andrea Tyson Independent Director
Matthew K. Rose Lead Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
AT&T7.88%233 835
CHINA MOBILE LTD.0.27%196 620
SOFTBANK GROUP CORP64.88%113 195
NTT DOCOMO INC-2.00%71 180
T-MOBILE US15.94%62 704
KDDI CORP-4.62%56 335